13.25 Welcome and introduction
13:30 Mike Laffan – COVID and coagulation
13:50 Alun Davies – Venous thromboembolism prophylaxis: Present and Future.
14:10 Anna Randi – Endothelial control of the pro/anti-coagulant balance: the missing link in the COVID19 coagulopathy?
14:30 Charis Pericleous- Vascular disease in the antiphospholipid syndrome: hypercoagulability and beyond
14:50 Claire Shovlin and Marcela Vizcaychipi – From front line to X line: Identification, prevention and elucidation of thrombosis in COVID-19
15:30 Josefin Ahnstroem – Factor V – a major determinant of thrombotic risk
15:50 Tom McKinnon – VWF as an anti-thrombotic target
16:10 Mike Emerson – Exploring the effects of antiretrovirals upon endothelial activation to identify avoidable drivers of cardiovascular risk in people living with HIV
16:30 Yun Xu – Multi-level modelling of thrombolysis in ischemic stroke.
17:30 End of meeting